Daily SPAC Update – Jan 17, 2024

by | Jan 17, 2024

Daily SPAC Update for Jan 17, 2024. Deal deck for ROCL + New Helium released. Tuesday’s winners and losers. Late VSAC deal and 3 extension votes.

Boardroom Alpha SPAC Resources
– Full SPAC Listing
– SPAC SEC Filings

SPAC DEALS ANNOUNCED
VSAC + Mediforum Co., Ltd

NEW DEAL DECKS
ROCL – ROTH CH ACQUISITION V CO + New Era Helium Corp
NCAC – Newcourt Acquisition Corp + Psyence Biomedical Ltd

EXTENSION VOTES
APAC – STONEBRIDGE ACQUISITION CORP * 6 monthly extensions to July 20, 2024
CLOE – CLOVER LEAF CAPITAL CORP * extend to July 22, 2024
TENK – TENX KEANE ACQUISITION * extend to Nov 18, 2024 (1 3-month ext, then 7 monthly)

SPAC VOTE RESULTS
GPAC – GLOBAL PARTNER ACQUISITION CORP II * Extend to Jul 14, 2024 * 1,503,254 redeemed

SPAC VOTES SET
OXUS – OXUS ACQUISITION CORP * Deal Vote Set: Feb 02, 2024 * trust $11.32
PPYA – PAPAYA GROWTH OPPORTUNITY CORP I * Extension Vote Set: Feb 13, 2024 * trust $10.88
AACI – ARMADA ACQUISITION CORP I * Extension Vote Set: Feb 13, 2024 * trust $10.96
ONYX – ONYX ACQUISITION CO I * Extension Vote Set: Jan 29, 2024 * trust $11.10

OTHER SPAC NEWS
DWAC PIPE problems

YESTERDAY’S TOP SPAC GAINERS
29.04% ~ $ 22.35 | DWAC – Digital World Acquisition Corp. (Announced)
3.60% ~ $ 11.31 | GTAC – Global Technology Acquisition Corp. I (Pre-Deal)
2.15% ~ $ 11.39 | BREZ – Breeze Holdings Acquisition Corp (Announced)
1.18% ~ $ 5.99 | DECA – Denali Capital Acquisition Corp. (Announced)
1.08% ~ $ 11.23 | ADRT – Ault Disruptive Technologies Corp (Pre-Deal)

YESTERDAY’S TOP SPAC LOSERS
-37.41% ~ $ 6.02 | NUBI – Nubia Brand International Corp. (Announced)
-22.58% ~ $ 9.02 | DMAQ – Deep Medicine Acquisition Corp. (Announced)
-18.83% ~ $ 3.34 | ATAK – Aurora Technology Acquisition Corp. (Announced)
-10.80% ~ $ 9.99 | NCAC – Newcourt Acquisition Corp (Announced)
-8.15% ~ $ 12.40 | MCAF – Mountain Crest Acquisition Corp. IV (Announced)

Recent Analysis

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.